• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虫草素、乳铁蛋白和羊栖菜多糖通过M2样巨噬细胞极化对呼吸道合胞病毒具有保护作用。

Cordycepin, lactoferrin, and Sargassum fusiforme polysaccharides protects against RSV via M2-like macrophage polarization.

作者信息

Fu Xiaozong, Huang Panwen, Zhang Yuting, Li Yanchang, Hu Shichang

机构信息

Preventive Health Care Department, Dongguan People's Hospital Xiegang Branch, Dongguan, Guangdong, China.

Department of Respiratory and Critical Care Medicine, Dongguan People's Hospital, Dongguan, Guangdong, China.

出版信息

Front Immunol. 2025 Jun 16;16:1576069. doi: 10.3389/fimmu.2025.1576069. eCollection 2025.

DOI:10.3389/fimmu.2025.1576069
PMID:40589746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12206873/
Abstract

BACKGROUND

Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infections, particularly in infants and the older population, with limited effective treatments available. Cordycepin, lactoferrin, and Sargassum fusiforme polysaccharides (CLS) are natural compounds with antiviral and immunomodulatory properties. This study investigates the therapeutic potential of CLS in RSV infection.

METHODS

A murine model of RSV infection was used to evaluate the effects of CLS. Lung pathology was assessed by lung index, histology, and bronchoalveolar lavage fluid (BALF) albumin and LDH levels. Viral load was measured by RSV mRNA and protein expression. Alveolar macrophage depletion was achieved using clodronate liposomes, and macrophage polarization was analyzed via flow cytometry and RT-qPCR.

RESULTS

CLS treatment improved lung pathology, reduced BALF injury markers, and decreased viral load. The therapeutic effects of CLS were abrogated by macrophage depletion, indicating a reliance on alveolar macrophages. CLS promoted M2-like macrophage polarization, increasing M2 markers and reducing M1 markers. , CLS reduced RSV-induced apoptosis and enhanced macrophage proliferation.

CONCLUSIONS

CLS protects against RSV-induced lung injury by promoting M2-like macrophage polarization and reducing viral load. These findings support CLS as a potential therapeutic for RSV infections.

摘要

背景

呼吸道合胞病毒(RSV)是呼吸道感染的主要病因,尤其是在婴儿和老年人群中,而有效的治疗方法有限。虫草素、乳铁蛋白和羊栖菜多糖(CLS)是具有抗病毒和免疫调节特性的天然化合物。本研究调查了CLS在RSV感染中的治疗潜力。

方法

使用RSV感染的小鼠模型来评估CLS的作用。通过肺指数、组织学以及支气管肺泡灌洗液(BALF)中的白蛋白和乳酸脱氢酶水平评估肺部病理情况。通过RSV mRNA和蛋白表达来测量病毒载量。使用氯膦酸脂质体实现肺泡巨噬细胞耗竭,并通过流式细胞术和RT-qPCR分析巨噬细胞极化情况。

结果

CLS治疗改善了肺部病理,降低了BALF损伤标志物,并降低了病毒载量。巨噬细胞耗竭消除了CLS的治疗效果,表明其依赖于肺泡巨噬细胞。CLS促进了M2样巨噬细胞极化,增加了M2标志物并减少了M1标志物。此外,CLS减少了RSV诱导的细胞凋亡并增强了巨噬细胞增殖。

结论

CLS通过促进M2样巨噬细胞极化和降低病毒载量来预防RSV诱导的肺损伤。这些发现支持CLS作为RSV感染的潜在治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/b396ecfa2cd8/fimmu-16-1576069-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/1478525597e2/fimmu-16-1576069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/3fd84032f112/fimmu-16-1576069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/cab3df651dee/fimmu-16-1576069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/56411c5c94d4/fimmu-16-1576069-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/b396ecfa2cd8/fimmu-16-1576069-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/1478525597e2/fimmu-16-1576069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/3fd84032f112/fimmu-16-1576069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/cab3df651dee/fimmu-16-1576069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/56411c5c94d4/fimmu-16-1576069-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb97/12206873/b396ecfa2cd8/fimmu-16-1576069-g006.jpg

相似文献

1
Cordycepin, lactoferrin, and Sargassum fusiforme polysaccharides protects against RSV via M2-like macrophage polarization.虫草素、乳铁蛋白和羊栖菜多糖通过M2样巨噬细胞极化对呼吸道合胞病毒具有保护作用。
Front Immunol. 2025 Jun 16;16:1576069. doi: 10.3389/fimmu.2025.1576069. eCollection 2025.
2
Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.恩格司托通过调节巨噬细胞吞噬能力来减少实验性呼吸道合胞病毒诱导的呼吸道炎症的发生。
PLoS One. 2018 Apr 19;13(4):e0195822. doi: 10.1371/journal.pone.0195822. eCollection 2018.
3
Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection.在一种新型的呼吸道合胞病毒感染新生鼠模型中,经鼻腔给予干扰素 γ 刺激未成熟肺巨噬细胞。
PLoS One. 2012;7(7):e40499. doi: 10.1371/journal.pone.0040499. Epub 2012 Jul 6.
4
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.使用帕利珠单抗对儿童进行呼吸道合胞病毒(RSV)免疫预防:一项系统评价与经济学评估
Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86. doi: 10.3310/hta12360.
5
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
6
Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice.肺泡巨噬细胞支持呼吸道合胞病毒感染的新生小鼠中干扰素γ介导的病毒清除。
Respir Res. 2015 Oct 5;16:122. doi: 10.1186/s12931-015-0282-7.
7
Inhibitory Effect of and Its Components on Replication of Respiratory Syncytial Virus In Vitro and In Vivo.及其中成分对呼吸道合胞病毒在体外和体内复制的抑制作用。
Viruses. 2021 Mar 25;13(4):548. doi: 10.3390/v13040548.
8
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.对帕利珠单抗用于呼吸道合胞病毒免疫预防给药依从性的系统评价。
J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46.
9
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
10
EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus.EDP-938对实验性感染呼吸道合胞病毒的健康成年人具有高耐药屏障。
J Infect Dis. 2025 Feb 20;231(2):e290-e298. doi: 10.1093/infdis/jiae471.

本文引用的文献

1
Recent Advances in the Structure, Extraction, and Biological Activity of Polysaccharides.多糖的结构、提取及生物活性的最新进展
Mar Drugs. 2025 Feb 23;23(3):98. doi: 10.3390/md23030098.
2
Clinical epidemiological characteristics of hospitalized pediatric viral community-acquired pneumonia in China.中国住院儿童病毒性社区获得性肺炎的临床流行病学特征
J Infect. 2025 Mar;90(3):106450. doi: 10.1016/j.jinf.2025.106450. Epub 2025 Feb 24.
3
Regulation of LPS-Induced Inflammatory Responses in Bovine Mammary Epithelial Cells via TLR4-Mediated NF-κB and MAPK Signaling Pathways by Lactoferrin.
乳铁蛋白通过TLR4介导的NF-κB和MAPK信号通路对脂多糖诱导的牛乳腺上皮细胞炎症反应的调节作用
Life (Basel). 2025 Jan 9;15(1):69. doi: 10.3390/life15010069.
4
Respiratory syncytial virus burden in children under 2 years old in understudied areas worldwide: gap analysis of available evidence, 2012-2022.全球未充分研究地区2岁以下儿童的呼吸道合胞病毒负担:2012 - 2022年现有证据的差距分析
Front Pediatr. 2024 Nov 21;12:1452267. doi: 10.3389/fped.2024.1452267. eCollection 2024.
5
Immune Responses to Respiratory Syncytial Virus Vaccines: Advances and Challenges.对呼吸道合胞病毒疫苗的免疫反应:进展与挑战
Microorganisms. 2024 Nov 13;12(11):2305. doi: 10.3390/microorganisms12112305.
6
Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue.抗呼吸道合胞病毒的疫苗和治疗药物:已解决和未解决的问题
MedComm (2020). 2024 Nov 21;5(12):e70016. doi: 10.1002/mco2.70016. eCollection 2024 Dec.
7
An Overview on Disease Burden and Management of Respiratory Syncytial Virus Infections in Older Adults in the Asia-Pacific Region.亚太地区老年人呼吸道合胞病毒感染的疾病负担和管理概述。
Rev Med Virol. 2024 Nov;34(6):e70003. doi: 10.1002/rmv.70003.
8
Recent advances in natural products and derivatives with antiviral activity against respiratory syncytial virus (RSV).具有抗呼吸道合胞病毒(RSV)活性的天然产物及其衍生物的最新进展。
J Asian Nat Prod Res. 2025 Apr;27(4):505-528. doi: 10.1080/10286020.2024.2417211. Epub 2024 Oct 19.
9
Lactoferrin: A Promising Therapeutic Molecule against Human Papillomavirus.乳铁蛋白:一种针对人乳头瘤病毒的有前途的治疗分子。
Nutrients. 2024 Sep 12;16(18):3073. doi: 10.3390/nu16183073.
10
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.呼吸道合胞病毒疫苗和单克隆抗体领域:通向全球可及之路。
Lancet Infect Dis. 2024 Dec;24(12):e747-e761. doi: 10.1016/S1473-3099(24)00455-9. Epub 2024 Sep 23.